Market Research Logo

OrbusNeich - Product Pipeline Analysis, 2016 Update

Summary

OrbusNeich is a medical device company that designs, develops, manufactures and markets medical devices for cardiovascular markets. It focuses on the development of cardiology devices for the treatment of vascular diseases. The company offers products that include bio-engineered stents, dual therapy stent, bare metal stents and balloons. OrbusNeich’s bio engineered stent is a pro-healing stent that utilizes immobilized antibodies to capture circulating endothelial progenitor cells. The company also conducts several clinical programs. It markets its products through the channel of network distributors. The company has its presence in the Netherlands, China, Japan, Hong Kong, Malaysia and Korea, among others. OrbusNeich is headquartered in Hong Kong.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company OrbusNeich
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


OrbusNeich Company Snapshot
OrbusNeich Company Overview
OrbusNeich Pipeline Products and Clinical Trials Overview
OrbusNeich – Pipeline Analysis Overview
Key Facts
OrbusNeich - Major Products and Services
OrbusNeich Pipeline Products by Development Stage
OrbusNeich Clinical Trials by Trial Status
OrbusNeich Pipeline Products Overview
Acute BRS
Acute BRS Product Overview
COMBO Dual Therapy Stent
COMBO Dual Therapy Stent Product Overview
COMBO Dual Therapy Stent Clinical Trial
COMBO Dual Therapy Stent - 38 mm
COMBO Dual Therapy Stent - 38 mm Product Overview
Cura Stent
Cura Stent Product Overview
ON-AVS Scaffold
ON-AVS Scaffold Product Overview
OrbusNeich - Key Competitors
OrbusNeich - Key Employees
OrbusNeich - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
OrbusNeich, Recent Developments
May 24, 2016: OrbusNeich Expands Portfolio To Include Scoreflex PTA balloon Catheter
May 24, 2016: OrbusNeich Introduces News JADE catheter to Treat Peripheral Disease
May 03, 2016: OrbusNeich Announces the Last Patient Enrollment in PhysicianInitiated Study to Evaluate the Potential for Shorter Dual Antiplatelet Therapy in ACS Patients
Feb 01, 2016: OrbusNeich highlights Sapphire II PRO at AsiaPCR/SingLIVE 2016
Feb 01, 2016: OrbusNeich showcases Scoreflex at AsiaPCR/SingLIVE 2016
Dec 17, 2015: OrbusNeich demonstrstes Scoreflex Coronary Dilatation Catheter at GulfPCR-GIM 2015
Dec 17, 2015: OrbusNeich demonstrates Sapphire II Coronary Dilatation Catheter at GulfPCR-GIM 2015
Oct 19, 2015: One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015
Jul 20, 2015: OrbusNeich Announces Enrollment of First Patient in China Recovery Study
Jun 04, 2015: COMBO Dual Therapy Stent demonstrates true tissue maturation with low clinical events rate out to 4 years at EuroPCR 2015
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
OrbusNeich Pipeline Products and Clinical Trials Overview
OrbusNeich Pipeline Products by Equipment Type
OrbusNeich Pipeline Products by Indication
OrbusNeich Clinical Trials by Trial Status
OrbusNeich, Key Facts
OrbusNeich, Major Products and Services
OrbusNeich Number of Pipeline Products by Development Stage
OrbusNeich Pipeline Products Summary by Development Stage
OrbusNeich Clinical Trials by Trial Status
OrbusNeich Clinical Trials Summary
Acute BRS - Product Status
Acute BRS - Product Description
COMBO Dual Therapy Stent - Product Status
COMBO Dual Therapy Stent - Product Description
COMBO Dual Therapy Stent - A Prospective, Multi-center, Randomized Controlled Trial Evaluating the Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients with De Novo Stenotic Lesions of Native Coronary Artery: RECOVERY
COMBO Dual Therapy Stent - China Recovery Study of COMBO Dual Therapy Stent
COMBO Dual Therapy Stent - Japan-USA Harmonized Assessment by Randomized, Multi-center Study of Orbusneich's Combo Stent (Japan-USA HARMONEE): Assessment of a Novel DES Platform for Percutaneous Coronary Revascularization in Patients with Ischemic Coronary Disease and NSTEMI Acute Coronary Syndrome
COMBO Dual Therapy Stent - Multicenter, Prospective, Clinical Outcomes after Deployment of the Abluminal Sirolimus Coated Bio-Engineered Stent (Combo Bio- Engineered Sirolimus Eluting Stent) Post Market Registry
COMBO Dual Therapy Stent - Multinational Abluminal Sirolimus Coated Bio-engineered Stent: The MASCOT Post Marketing Registry
COMBO Dual Therapy Stent - Prospective, Multi-centre, Randomized, Parallel Comparison to Evaluate the Safety and Efficacy of the Abluminal Sirolimus Coated Bio-engineered Stent (COMBO Stent) in Association with Short-term Single Antiplatelet Therapy in Patients with Coronary Artery Disease with an Indication for Chronic Oral Anticoagulant Therapy as Compared to a Guidelines-based Strategy
COMBO Dual Therapy Stent - 38 mm - Product Status
COMBO Dual Therapy Stent - 38 mm - Product Description
Cura Stent - Product Status
Cura Stent - Product Description
ON-AVS Scaffold - Product Status
ON-AVS Scaffold - Product Description
OrbusNeich, Key Employees
OrbusNeich, Other Locations
OrbusNeich, Subsidiaries
List of Figures
OrbusNeich Pipeline Products by Equipment Type
OrbusNeich Pipeline Products by Development Stage
OrbusNeich Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report